Literature DB >> 34313659

Cementless reverse total shoulder arthroplasty in a patient affected by Osteogenesis Imperfecta: a case report and review of the literature.

Francesco Mancuso1, Paolo Di Benedetto2, Andrea Marchetti3, Dario Ghassempour4, Alessandro Beltrame5, Araldo Causero6.   

Abstract

BACKGROUND AND AIM OF THE WORK: Osteogenesis Imperfecta is a rare genetic condition. The use of total shoulder arthroplasty in these patients is very uncommon, with only two cases reported in the literature. This study describes a cementless reverse total shoulder arthroplasty (rTSA) for a multi-fragmented fracture in a patient affected by Osteogenesis Imperfecta (OI) type 1 and aims to review literature results of shoulder replacement in patients affected by this uncommon condition.
METHODS: the case of a woman affected by OI type 1 treated with a cementless rTSA for a multi-fragmented proximal humerus facture is reported. Focusing on the fixation technique, a research of all articles regarding the orthopaedic treatments in patients affected by Osteogenesis Imperfecta was performed and compared to the techniques used in the unaffected population. RESULT: Our patient shows good results in terms of clinical and radiological outcomes at the short term follow up. Few studies treat the orthopaedic manifestation of this rare genetic condition and only two are focused on shoulder arthroplasty. Cement is the preferred method for fixation in both papers.
CONCLUSION: Cementless reverse shoulder arthroplasty may be an option in patients affected by OI type 1, although literature seems to support cement as the fixation method of choice.

Entities:  

Mesh:

Year:  2021        PMID: 34313659      PMCID: PMC8420817          DOI: 10.23750/abm.v92iS3.11756

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


Introduction

Reverse total shoulder arthroplasty (rTSA) has been used in Europe for almost 20 years. Originally indicated for patients with rotator cuff arthropathy, in the last few years rTSA has been used to treat various other pathologies including displaced proximal humeral fractures in elderly patients. We present the case of a cementless rTSA in a patient affected by Osteogenesis Imperfecta (OI).

Case report

A 70-years old right hand-dominant woman affected by Osteogenesis Imperfecta type 1 came to our emergency department complaining of severe left shoulder pain, swelling and functional limitation after a domestic fall. Before the trauma, the patient was used to live alone and was able to perform activities of daily living, with some limitation due to her genetic pathology. As a teenager, she was diagnosed with OI type I due to blue sclerae, several fractures (more than 30 reported events) that never required surgery. The patient has many other comorbidities including blindness secondary to glaucoma, juvenile cataract, retinal detachment, right-convex dorsal scoliosis and osteoporosis treated with annual infusion of zoledronic acid. Clinical examination failed to show any neurovascular deficits or other injuries. Plain radiographs of the shoulder detected a 4-fragments proximal humerus fracture (Fig. 1). A CT scan was performed and confirmed the displaced multi-fragmented fracture of the proximal humerus, with subluxation of the humeral head (Fig. 2).
Figure 1.

Plain radiographs (antero-posterior view) obtained the day of trauma showing the 4-fragments proximal humerus fracture

Figure 2.

CT scan (coronal and axial view) obtained the day of trauma (A), (B) Left shoulder, multi-fragmented fracture of the proximal humerus, with subluxation of the humeral head

Plain radiographs (antero-posterior view) obtained the day of trauma showing the 4-fragments proximal humerus fracture CT scan (coronal and axial view) obtained the day of trauma (A), (B) Left shoulder, multi-fragmented fracture of the proximal humerus, with subluxation of the humeral head A reverse shoulder arthroplasty was preferred over a syntesis because of the fragmentation and the poor quality of the bone stock. Appropriate informed consent was obtained. The patient was placed in beach-chair position and a delto-pectoral approach was performed. The main cephalic fragment was identified and removed without the need of further humeral head osteotomy. A small size metallic glenoid component fixed with two screws and a 40 mm glenosphere were implanted. A preventive bone cerclage on the proximal humeral diaphysis was performed to avoid further rim fracture propagation. A medium size cementless SMR reverse shoulder arthroplasty prosthesis (Lima Corporate, San Daniele del Friuli, Italy) was implanted as our experience leads to prefer (1). Postoperative plain radiographs were obtained (fig 3).
Figure 3.

Postoperative plain radiographs. (A), (B) Antero-posterior and axial view of the left shoulder

Postoperative plain radiographs. (A), (B) Antero-posterior and axial view of the left shoulder Postoperative course was uneventful with the patient discharged at home three days after the operation without complications. The involved arm was hold in brace during rest for three weeks with early passive and assisted active mobilization allowed. After one month, the patient was able to achieve 40° active abduction and flexion, 10° active extra-rotation and internal rotation at the trochanteric region with pain. At 6-months follow-up, the patient improved the range of motion with decreased pain intensity. She was able to perform 75° active abduction and 85° active flexion, 30° active extra-rotation and intra-rotation to lumbar spine. Usual radiographic controls showed good positioning of the implant components without signs of osteolysis or mobilization (Fig. 4).
Figure 4.

Six months follow up radiographs. (A), (B) Antero-posterior view of the left shoulder

Six months follow up radiographs. (A), (B) Antero-posterior view of the left shoulder

Discussion

Osteogenesis Imperfecta, also known as "brittle bone disease", is a heritable group of collagen-related disorders that may cause many orthopaedic manifestations. It involves a heterogeneous group of genetic conditions characterized by increased bone fragility, low bone mass, and susceptibility to bone fractures which are prone to nonunion and malunion. (2) The classification of Silence corresponds better with the genetics basis of OI. (3) This disease is known mainly for its skeletal manifestations in pediatric age, as it is frequently reported in literature. Actually, few studies deal with the consequences on adult individuals, even if more than 25% of lifetime fractures are reported to occur during adulthood (4,5). The literature is very limited and focuses mainly on joint replacement of the lower limbs. Papagelopoulos and Morrey retrospectively analysed the Mayo Clinic registry from 1969 to 1990 by reviewing the outcomes of cemented total hip arthroplasty (THA) and total knee arthroplasty (TKA) in patients with OI. At the end of the follow-up, 7 and 10 years, they found no complications or radiographic signs of osteolysis or mobilization. (3) In a case series, Krishnan et al retrospectively reviewed 4 patients and 6 uncemented THA. The authors described a higher complication and revision rate, with four intraoperative femoral fractures, one acetabulum fracture and four postoperative acetabular protrusions. (6) In line with these experiences, Roberts et al recently recommend the use of cemented implants to respect the increased bone fragility of those patients. (5) Therefore, limited cohorts recommend caution during the femoral canal preparation and stem implant to prevent iatrogenic fractures that are very common and can affect final outcomes. (6,7) According to these indications, in our case, a preventive bone cerclage to avoid any iatrogenic damage was performed. Lower limbs have higher functional demands because they involve joints which work under weight bearing. This physiological situation combined with bone fragility due to OI, leads the surgeons to prefer the use of cemented implants. Moreover, few publications deal with shoulder replacement in patients suffering from OI. Mnif et al reported the case of bilateral posterior fracture-dislocation of the shoulders in a man with OI treated with a bilateral cemented total shoulder arthroplasty with successful outcomes after 3 years of follow-up. (8) McLaughlin et al described the case of a patient with OI type I complicated by a proximal humeral enchondroma and a rotator cuff tear treated with a cemented reverse shoulder arthroplasty with good clinical and radiographic outcomes at 5 months of follow-up. (9) Therefore, this suggests that upper extremity arthroplasty may be an effective treatment option for post-traumatic injuries in patients with OI and rTSA could be an effective technique using a cemented fixation, if a rotator cuff tear is present. However, there is no evidence against the choice of a cementless fixation technique for rTSA. The challenge was to use a cementless technique also in a patient affected by OI using the rational concept that the upper limb has fewer functional demands, being not heavily stressed as the lower limbs. Several studies discuss the difference between cemented or cementless rTSA in patients with healthy bone. Wright et al suggested that cementless rTSA offers good clinical outcomes and stable fixation with a low rate of complications in treatment of 3- and 4-parts proximal humeral fractures advising that cement may be not necessary. (10) Youn et al, in a radiological focused study, reported that the cementless nature of the humeral component did not result in early loosening or failure of the implant. (11) In a retrospective cohort study, Wiater et al demonstrated that uncemented stems have at least equivalent clinical and radiographic outcomes compared with cemented stems but a better complication profile. (12) Phadnis et al, reviewing 41 clinical studies, demonstrated that the cementless stems have significantly lower incidence of postoperative acromion fractures but a higher incidence of non-progressive radiolucent lines at two years. (13) Concerning this, Castagna et al reported that these lines, commonly seen in uncemented stems, do not appear to compromise the fixation or the clinical outcomes in a mid-term follow-up. (14) According to these evidences, cementless rTSA is becoming the preferred therapeutic approach at our institution for comminuted proximal humeral fractures and cuff tear arthropathy in otherwise healthy patients. (15) This because the cementless technique reduces the operating time, avoids the morbidity associated with the use of cement and allows the realignment or exchange of the humeral component during surgery. Moreover, in our experience the use of cement could significantly complicate a future revision surgery that may be frequent in these patients. (6)

Conclusion

Shoulder replacement and fixation could be challenging and technically demanding for the orthopaedic surgeon, especially in those patients with extreme bone fragility. Literature agrees on the indication to cement lower limb joints replacements while little has been written about shoulders. Our experience, considering the good outcome though after a short follow-up, highlights that the cementless rTSA may be an option also in patients with a poor bone quality as it usually happens in OI. Longer follow up is obviously required to draw further conclusions while controlled trials may be difficult to conduct due to the low prevalence of OI.
  15 in total

1.  Bilateral posterior fracture dislocation of the shoulder.

Authors:  H Mnif; M Koubaa; M Zrig; S Zrour; K Amara; N Bergaoui; A Abid
Journal:  Chir Main       Date:  2009-12-09

2.  Clinical and radiographic results of cementless reverse total shoulder arthroplasty: a comparative study with 2 to 5 years of follow-up.

Authors:  J Michael Wiater; James E Moravek; Matthew D Budge; Denise M Koueiter; David Marcantonio; Brett P Wiater
Journal:  J Shoulder Elbow Surg       Date:  2014-02-20       Impact factor: 3.019

3.  Do radiolucent lines and stress shielding of the humeral shaft really matter in shoulder arthroplasty?

Authors:  A Castagna; G Delle Rose; S De Giorgi; S Gumina; R Garofalo; M Borroni
Journal:  J Biol Regul Homeost Agents       Date:  2020 Jul-Aug       Impact factor: 1.711

Review 4.  Challenges of Fracture Management for Adults With Osteogenesis Imperfecta.

Authors:  Joseph A Gil; Steven F DeFroda; Kunal Sindhu; Aristides I Cruz; Alan H Daniels
Journal:  Orthopedics       Date:  2016-10-13       Impact factor: 1.390

5.  Uncemented Reverse Total Shoulder Arthroplasty as Initial Treatment for Comminuted Proximal Humerus Fractures.

Authors:  Jon O Wright; Anthony Ho; Jeremy Kalma; Denise Koueiter; Jason Esterle; David Marcantonio; J Michael Wiater; Brett Wiater
Journal:  J Orthop Trauma       Date:  2019-07       Impact factor: 2.512

Review 6.  Functional and radiologic outcomes of uncemented reverse shoulder arthroplasty in proximal humeral fractures: cementing the humeral component is not necessary.

Authors:  Seung-Min Youn; Shaneel Deo; Peter C Poon
Journal:  J Shoulder Elbow Surg       Date:  2015-12-02       Impact factor: 3.019

Review 7.  Total knee arthroplasty with concurrent femoral and tibial osteotomies in osteogenesis imperfecta.

Authors:  Russell Wagner; Colten Luedke
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2014-01

Review 8.  Osteogenesis imperfecta.

Authors:  Joan C Marini; Antonella Forlino; Hans Peter Bächinger; Nick J Bishop; Peter H Byers; Anne De Paepe; Francois Fassier; Nadja Fratzl-Zelman; Kenneth M Kozloff; Deborah Krakow; Kathleen Montpetit; Oliver Semler
Journal:  Nat Rev Dis Primers       Date:  2017-08-18       Impact factor: 52.329

9.  The SMR reverse shoulder arthroplasty in rotator cuff arthropathy management.

Authors:  Alessandro Beltrame; Paolo Di Benedetto; Daniele Salviato; Giuseppe Niccoli; Renato Gisonni; Vanni Cainero; Araldo Causero
Journal:  Acta Biomed       Date:  2017-10-18

10.  Onlay versus Inlay humeral steam in Reverse Shoulder Arthroplasty (RSA): clinical and biomechanical study.

Authors:  Alessandro Beltrame; Paolo Di Benedetto; Chiara Cicuto; Vanni Cainero; Renato Chisoni; Araldo Causero
Journal:  Acta Biomed       Date:  2019-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.